Ayoxxa Raises $3.4M to Develop Protein Bead Array Platform | GenomeWeb

NEW YORK (GenomeWeb News) – Ayoxxa Biosystems announced today that it has netted €2.6 million ($3.4 million) in a Series A financing round.

The Cologne, Germany-based firm said it will use the proceeds to further develop and scale-up production of in situ encoded bead-based arrays that allow the simultaneous measurement of multiple proteins from small amounts of sample material.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.